Clinical trial
Randomized, Double-masking, Placebo-controlled, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of Ginkgo Biloba Dropping Pills in the Treatment of Coronary Heart Disease With Stable Angina Pectoris and Depression
NCT04529148 is registered in ClinicalTrials.gov with Wanbangde Pharmaceutical Group Co., LTD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Double-masking, Placebo-controlled, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of Ginkgo Biloba Dropping Pills in the Treatment of Coronary Heart Disease With Stable Angina Pectoris and Depression
- Lead sponsor
- Wanbangde Pharmaceutical Group Co., LTD
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2020
- Completion date
- August 18, 2022
- Enrollment
- 74 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
stable angina pectoris associated with depression